Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

Condition:   Arthritis, Rheumatoid Interventions:   Biological: GSK3196165;   Drug: csDMARD(s) Sponsors:   GlaxoSmithKline;   Iqvia Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials